Fluvoxamine (Luvox)

Fluvoxamine is the SSRI nobody thinks of first, and that’s a shame, because for one specific job it’s still the one I reach for. The job is OCD. The actual obsessive-compulsive disorder kind, where a thirty-second hand wash turns into forty minutes and the patient knows it’s irrational and can’t stop anyway. Luvox earns its keep there. Depression, generalized anxiety, the catch-all serotonin pitch you see on the back of a sample box, those aren’t really what this drug is for, and the data backs that up.

It was the first SSRI to get an FDA nod for OCD back in 1994, and it kept the pediatric OCD indication when most of its cousins were still arguing about safety in kids. Then it slowly faded from the depression conversation as Zoloft, Lexapro, and Prozac took up all the oxygen. Which is fine. Fluvoxamine was never a great depression drug. It’s a great OCD drug that got marketed like a general SSRI and then quietly walked back into its lane.

The interesting thing is what it does at higher doses, and the weird CYP1A2 problem, and then a brief pandemic-era detour into sigma-1 receptor research that nobody saw coming. Worth pulling apart.

Why fluvoxamine wins at OCD specifically

Every SSRI works for OCD on paper. Sertraline, fluoxetine, paroxetine, and fluvoxamine all carry the indication, and citalopram and escitalopram get used off-label constantly. The reason fluvoxamine still sits at the top of my OCD shortlist comes down to two related things.

Two reasons, and they’re related. First, OCD responds to serotonin loading at doses that would knock most depressed patients sideways. We’re talking about Zoloft at 200mg, Prozac at 80mg, fluvoxamine at 200 to 300mg. The depression dose is the bottom of the OCD dose range. OCD wants more drug, and it wants it for longer before you can call the trial a failure. Three months minimum at a real dose. Most patients I see who say “the SSRI didn’t work for my OCD” never got past 100mg of anything and quit at week six.

Second, fluvoxamine tolerates the climb. The dosing range goes from 50mg at bedtime up to 300mg total daily, usually split because the half-life is short. That’s a wider therapeutic window than some of its cousins, and the patients I’ve pushed up to 250 or 300mg generally tolerate it better than I would have expected. The sedation can actually be useful in an OCD patient whose head won’t shut off at night. You give it at bedtime and the drowsiness is a feature, not a bug.

I had a college kid a couple of winters back, nineteen years old, contamination OCD that had eaten his freshman year. Couldn’t touch doorknobs, was burning through hand sanitizer like it was water, washing until his knuckles bled. We’d been through sertraline at 200mg for four months with maybe 20% improvement. Switched him to fluvoxamine, took him slowly up to 250mg over about ten weeks, paired with ERP therapy with a real exposure therapist (not a chat therapist, the homework-and-discomfort kind). By summer he was washing his hands a normal number of times and back in the dorm. The drug wasn’t magic. The drug got him to a place where the therapy could land.

The pediatric OCD niche

This is where fluvoxamine still gets pulled off the shelf the most in my practice. It’s approved for OCD in kids from age 8 and up, which is younger than most psychiatric drugs are comfortable going. Sertraline carries the pediatric OCD nod too, and fluoxetine, but fluvoxamine has the longest track record in this age group.

Pediatric OCD is its own animal. These kids aren’t anxious in the way most parents picture. They’re stuck in mental loops, performing rituals, asking the same reassurance question forty times in an afternoon. Untreated, it ossifies into a personality structure by the late teens, and the work to undo it gets harder every year. The window where treatment is most effective is roughly ages 8 to 14, which is exactly the window where parents tend to wait and hope it passes.

The dose in kids starts low. 25mg at bedtime, sometimes lower for the smaller ones. You climb slowly, paying attention to behavioral activation, sleep, appetite. Pair it with ERP from a child-specialized therapist (not optional, the meds don’t do this alone), and you get response rates that are genuinely impressive for psychiatric pediatrics. Not cures. Meaningful improvement in maybe 60-70% of kids who get a real trial.

Fluvoxamine doesn’t fix OCD. It turns the volume down enough that the exposure work can actually happen.

The CYP1A2 problem you have to know about

This is the thing that scares prescribers off fluvoxamine, and it’s the reason I always make sure I’ve actually mapped a patient’s other medications before I start. Fluvoxamine is a potent inhibitor of the CYP1A2 enzyme, and a handful of important drugs depend on CYP1A2 to get out of the body.

Clozapine is the big one. Anyone on clozapine for treatment-resistant schizophrenia is already walking a tightrope with blood levels. Add fluvoxamine and clozapine levels can double or triple. Some psychiatrists actually use this combination on purpose at low fluvoxamine doses (25-50mg) to boost clozapine and reduce the metabolite that drives some of the side effects, but it’s a deliberate, monitored move with regular levels drawn. Bumping into it accidentally is dangerous.

Theophylline, still around for some pulmonary patients, has a narrow therapeutic window and gets cleared by CYP1A2. Add fluvoxamine and you can push theophylline into toxic territory. Same general story with tizanidine, which is on the contraindicated list outright, and with several tricyclics.

And caffeine. Yes, really. Fluvoxamine slows caffeine clearance significantly. Patients on fluvoxamine who are also putting away four espressos a day will feel jittery and sleep poorly and not understand why. I tell them to cut caffeine roughly in half when starting, see how they feel, and titrate from there. Most don’t, then they call me at week three wondering why they can’t sleep.

The COVID detour and sigma-1 weirdness

Around late 2020, fluvoxamine had a strange moment in the sun. A couple of studies, the TOGETHER trial being the most cited, suggested early fluvoxamine reduced hospitalization in outpatient COVID. The proposed mechanism wasn’t anything to do with serotonin. It was sigma-1 receptor agonism, an off-target action that fluvoxamine has more than most SSRIs, and which seems to dampen the inflammatory cytokine response. The data was suggestive, not conclusive, and follow-up studies were more mixed.

I bring it up not because I’m prescribing fluvoxamine for long COVID (I’m not, the evidence isn’t there), but because the sigma-1 story is interesting on its own and might matter for psychiatric uses we haven’t pinned down yet. Sigma-1 is involved in neuroprotection, ER stress responses, and possibly the speed of antidepressant response. There’s a small literature on whether the sigma-1 effect is part of why fluvoxamine seems to work faster than some SSRIs in some patients. Don’t bank on it. But it’s there.

When I think of fluvoxamine now

These days fluvoxamine lives in two slots in my brain. First slot: pediatric OCD, especially the under-12 crowd where the safety database matters and where pairing the meds with ERP is the real plan. Second slot: adult OCD that hasn’t responded to a real trial of sertraline or fluoxetine at high doses, where I want a different receptor profile and the option to push the dose hard.

I almost never reach for it as a first-line antidepressant anymore. The sedation, the short half-life requiring twice-daily dosing at higher levels, the GI side effects in the first two weeks, the CYP1A2 trap, all of that adds up to a drug that’s just less convenient than escitalopram or sertraline if depression is what you’re treating. If OCD shows up in the same patient, that calculation flips.

The patients who do best on fluvoxamine are the ones whose prescriber explained the climb and the timeline up front. Three months. Higher dose than your friend on Zoloft. Probably less coffee. Real exposure work alongside. If you skip any of that, the drug looks like it failed, and another SSRI gets blamed for not fixing OCD when nothing was going to fix OCD by itself.